Keymed Biosciences Inc. (HKG:2162)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
48.00
-0.10 (-0.21%)
Apr 3, 2025, 4:08 PM HKT

Keymed Biosciences Revenue

In the year 2024, Keymed Biosciences had annual revenue of 428.12M CNY with 20.91% growth. Keymed Biosciences had revenue of 373.44M in the half year ending December 31, 2024, with 592,665.08% growth.

Revenue
428.12M CNY
Revenue Growth
+20.91%
P/S Ratio
27.60
Revenue / Employee
340.32K CNY
Employees
1,258
Market Cap
13.23B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024428.12M74.03M20.91%
Dec 31, 2023354.10M254.03M253.87%
Dec 31, 2022100.06M-10.21M-9.26%
Dec 31, 2021110.27M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition